MDM2’s Influence on GRK2 Activity: MDM2 has been shown to regulate cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptors [39], highlighting its potential as a therapeutic target in heart diseases. The gene discussed is GRK2; the disease is heart disorder.